Camelot Portfolios, LLC Amgen Inc Transaction History

Camelot Portfolios, LLC

$179 Million
Q2 2024

A detailed history of Camelot Portfolios, LLC transactions in Amgen Inc stock. As of the latest transaction made, Camelot Portfolios, LLC holds 500 shares of AMGN stock, worth $160,955. This represents 0.09% of its overall portfolio holdings.

Number of Shares

500

Holding current value

$160,955

% of portfolio

0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $131,375 - $159,655	500 New	500 $156,000
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $1.9 Million - $2.33 Million	-9,602 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $911 - $1,208	5 Added 0.05%	9,602 $1.95 Million
Q4 2019 Jan 16, 2020	BUY	$189.21 - $243.2 $1.12 Million - $1.44 Million	5,932 Added 161.86%	9,597 $2.31 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $7,001 - $8,207	42 Added 1.16%	3,665 $675,000
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $1,989 - $2,242	-11 Reduced 0.3%	3,623 $688,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $648,305 - $756,780	3,634 New	3,634 $707,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1.38 Million - $1.56 Million	-7,467 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $1.24 Million - $1.39 Million	7,467 New	7,467 $1.38 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $1.18 Million - $1.38 Million	-6,976 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $293,019 - $327,392	-1,736 Reduced 19.93%	6,976 $1.21 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.46 Million - $1.66 Million	8,712	8,712 $1.62 Million

Others Institutions Holding AMGN

# of Institutions

3,082

Shares Held

417M

Call Options Held

7.24M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.

Account

Camelot Portfolios, LLC Amgen Inc Transaction History